News JanOne Inc.

Equities

JAN

US47089W1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
5.1 ^USD	+8.28%		+28.46%	+818.92%

Apr. 18	JanOne Files Prospectus for $100 Million Mixed Shelf Offering	MT
Apr. 15	North American Morning Briefing : Stock Futures -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JanOne Files Prospectus for $100 Million Mixed Shelf Offering	Apr. 18	MT
North American Morning Briefing : Stock Futures -2-	Apr. 15	DJ
JanOne Inc. Reports Earnings Results for the Full Year Ended December 30, 2023	Apr. 08	CI
JanOne Regains Compliance with Nasdaq's Listing Requirements	Mar. 15	PR
JanOne Inc. announced that it expects to receive $0.6 million in funding	Feb. 22	CI
JanOne Inc. announced that it expects to receive $0.3 million in funding from Live Ventures Incorporated	Feb. 06	CI
JanOne Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech	Nov. 09	MT
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	Nov. 09	MT
Top Premarket Gainers	Nov. 09	MT
JanOne to Present at the Dawson James 8th Annual Investment Conference	23-09-21	PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference	23-08-31	PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain	23-08-29	PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	23-08-28	AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	23-08-25	PR
JanOne Raises $790,000 in Registered Direct Offering of Shares, Private Placement of Warrants	23-08-23	MT
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules	23-08-22	PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting	23-08-21	AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules	23-08-21	AQ
JanOne Prices Registered Direct Offering, Announces Concurrent Private Placement	23-08-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News JanOne Inc.

Equities

JAN

US47089W1045

Summary

Filters